Here's an opportunity to impress upon students the importance of not publishing the same data twice (at least, not without being very explicit that this is what one is doing).
'...the ClinPsyc blog (clinpsyc.blogspot.com <http://clinpsyc.blogspot.com>) has spotted that the drug company Lilly has published identical data on duloxetine - a newish antidepressant drug - twice over, in two entirely separate scientific papers.... There are several reasons why this is interesting. Firstly, duplicate publication distorts a reader's impression of how much evidence is out there. If you think there are two trials showing that something works, then obviously that's much more impressive than if there's just one. "Of course I prescribe it," you can hear the doctors say. "I've seen two trials showing that it works."' For the rest of the article, see: http://www.guardian.co.uk/commentisfree/2008/oct/25/medical-research-science-health By the way, if you haven't already discovered it, The Guardian has one of the best science sections of any newspaper around. Regards, Chris -- Christopher D. Green Department of Psychology York University Toronto, ON M3J 1P3 Canada 416-736-2100 ex. 66164 [EMAIL PROTECTED] http://www.yorku.ca/christo/ ========================== --- To make changes to your subscription contact: Bill Southerly ([EMAIL PROTECTED])
